Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,373.1
15.9 (0.47%)

 

  • STI Straits Times Index
    3,373.1
    15.9 (0.47%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,655.7
    0.3 (0.02%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,466.5
    95.2 (0.34%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,899.9
    13.0 (0.45%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    21,620.9
    204.1 (0.95%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,403.8
    -29.7 (-0.46%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,101.4
    8.1 (0.39%)
    Index delayed 20 minutes
  • XAO XAO
    6,812.5
    31.3 (0.46%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,090.1M
  • Value: 895.3M
  • Rise: 221
  • Fall: 157
  • Unch: 460

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sinwa0.047+0.016
DISA0.002-
Accrelist0.004+0.002
Singapore-eDev0.051+0.015
Jadason^0.045+0.005
Sino Grandness0.051+0.001
SingTel3.520-
Sen Yue0.039-
Genting Sing0.935+0.010
Tritech0.029-

World Indices

World Indices
Name Last Change
Nasdaq 8,204.1 +57.6
HSI 28,466.5
HSCEI 10,809.9
Jakarta 6,403.8
Nikkei 225 21,620.9
SSE Comp 2,899.9
Shanghai A 3,037.4
Shanghai B 287.4
ShenZhen A 1,616.6
ShenZhen B 967.4
PSE Comp 0.0
KOSPI 2,101.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

CORREVIO PHARMA CORP CORREVIO PHARMA CORP.
Updated on 22 Jul 2019 (End of trading day)
Last (USD): 1.910 Change: -0.030 High: 1.950 Remarks: -
Change (%): -1.55 Low: 1.855
Open 1.950 Yesterday's Close 1.94
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 17,946 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.52011 Trailing EPS (USD) e -0.53692 NAV (USD) b 0.1922
PE a - Trailing PE f - Price / NAV b 9.9376
Dividend (USD) d - Cash In Hand (USD) g 0.5616 Issued & Paid-up Shares c 31,876,000
Dividend Yield (%) d - Price / Cash In Hand g 3.401 Treasury Shares h -
Beta - 75 Daysi 0.004 R-Squared - 75 Days(%)i 0.03 Market Cap (M) 60.883
Beta - 500 Daysi -0.169 R-Squared - 500 Days (%)i 0.14 Enterprise Value (M) 87.839
Piotroski F Score 1 Exchange Code CORV Par Value ( $ ) n.a.
52 Weeks Volatility (%) 82.26 Free Float (%) 69.1
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 14 Jun 2018.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 14 Jun 2018.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference CORREVIO PHARMA CORP NASDAQ 60.883 - - 9.9376 -
Industry Biotechnology NASDAQ 2,269.335 128.905 100.565 5.3938 0.788
Local Peer AMGEN INC NASDAQ 107,281.643 12.781 13.286 9.9042 3.099
Local Peer GILEAD SCIENCES INC NASDAQ 82,536.960 15.131 14.008 3.7601 3.541
Local Peer CELGENE CORP NASDAQ 63,099.612 15.596 13.298 7.7281 -
Local Peer BIOGEN INC NASDAQ 45,076.245 10.174 9.659 3.2593 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 44,585.544 21.268 20.691 9.4395 -
Local Peer ILLUMINA INC NASDAQ 43,847.160 53.084 51.524 11.0031 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 32,509.964 13.300 13.392 3.4421 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 27,428.670 353.465 65.871 2.8258 -
Local Peer INCYTE CORPORATION NASDAQ 17,521.811 160.027 69.271 8.4015 -
Local Peer EXACT SCIENCES CORP NASDAQ 14,986.581 - - 19.2893 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 14,612.194 - - 4.9759 -
Local Peer SEATTLE GENETICS INC NASDAQ 12,302.040 - - 9.6727 -
Other Local Peers SAREPTA THERAPEUTICS INC (NASDAQ), ARRAY BIOPHARMA INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BLUEBIRD BIO INC (NASDAQ), EXELIXIS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), MODERNA INC (NASDAQ), REPLIGEN CORP (NASDAQ), FIBROGEN INC (NASDAQ), TILRAY INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ALKERMES PLC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), GENOMIC HEALTH INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), REGENXBIO INC (NASDAQ), NATERA INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), VERACYTE INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), OPKO HEALTH INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), INTREXON CORP (NASDAQ), EPIZYME INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), RETROPHIN INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), ALDER BIOPHARMACEUTICALS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), OMEROS CORP (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), MACROGENICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), AVROBIO INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), PERSONALIS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), UROGEN PHARMA LTD (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), SYNTHORX INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), TRANSLATE BIO INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), DERMIRA INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), NEXTCURE INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), MEDICINOVA INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), RESTORBIO INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), PROTHENA CORP PLC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), MERUS B V (NASDAQ), AVID BIOSERVICES INC (NASDAQ), IMMUNOGEN INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), AGENUS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), XBIOTECH INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), KAMADA (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), GERON CORP (NASDAQ), ATHERSYS INC (NASDAQ), SYNLOGIC INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), COMPUGEN (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), MANNKIND CORPORATION (NASDAQ), CHIASMA INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), CHIMERIX INC (NASDAQ), AFFIMED N V (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), XOMA CORP (NASDAQ), AXCELLA HEALTH INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), ARDELYX INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), IMV INC (NASDAQ), TOCAGEN INC (NASDAQ), NANTKWEST INC (NASDAQ), SESEN BIO INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), NOVAVAX INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), INMUNE BIO INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), VERASTEM INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), EQUILLIUM INC (NASDAQ), SAVARA INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), TREVENA INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), CURIS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), EDAP TMS S.A. SPON ADS EACH REPR 1 ORD SHARE (NASDAQ), OTONOMY INC (NASDAQ), INFLARX N V (NASDAQ), VERMILLION INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), ORGENESIS INC (NASDAQ), COHBAR INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), ARAVIVE INC (NASDAQ), AQUINOX PHARMACEUTICALS INC (NASDAQ), IMMUTEP LTD SPON ADR EACH REP 100 ORD SHS (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), VACCINEX INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), IVERIC BIO INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), FORWARD PHARMA AS SPON ADR EACH REP 2 ORD SHS (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), ZAFGEN INC (NASDAQ), EVOGENE LTD (NASDAQ), CONTRAFECT CORP (NASDAQ), SENESTECH INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), SOPHIRIS BIO INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), SOLIGENIX INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), BIOCEPT INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), HISTOGENICS CORP (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), PRECIPIO INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), VICAL INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), NOVELION THERAPEUTICS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ATYR PHARMA INC (NASDAQ), VAXART INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADR EA REPR 150 ORD(POST SPLIT) (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), TROVAGENE INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADR EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), BENITEC BIOPHARMA LTD SPON ADR EA REPR 20 ORD (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), ADVAXIS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), OPGEN INC (NASDAQ), NEURALSTEM INC (NASDAQ), CYTORI THERAPEUTICS INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADR EACH REP 20 ORD SHS (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH (NASDAQ)
Global Peer AMGEN-T HKEx 609,936.000 9.271 9.631 7.1731 4.272
Global Peer CSL ASX 101,018.277 45.273 41.466 14.6569 1.022
Global Peer AGILENT TECHNOLOGIES INC NYSE 21,831.956 69.089 19.545 4.2599 0.868
Global Peer SINO BIOPHARM HKEx 117,659.160 10.981 11.271 3.3944 0.782
Global Peer WUXI BIO HKEx 101,673.440 136.127 136.126 11.1536 -
Global Peer BEIGENE HKEx 59,869.452 - - 4.7407 -
Global Peer Lonza SGX 5,937.453 7.663 7.663 0.6889 4.766
Global Peer GENSCRIPT BIO HKEx 33,253.760 199.978 199.985 8.8734 -
Global Peer 3SBIO HKEx 32,796.835 21.680 21.680 3.3386 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 2,194.266 34.996 52.634 2.2220 -
Other Global Peers HAOHAI BIOTEC (HKEx), FRONTAGE (HKEx), VIVA BIOTECH (HKEx), ASCLETIS-B (HKEx), POLYNOVO LIMITED (ASX), MYOVANT SCIENCES LTD (NYSE), AVITA MEDICAL LTD (ASX), CKLIFE SCIENCES (HKEx), MESOBLAST LTD (ASX), ESSEX BIO-TECH (HKEx), NEXT SCIENCE LTD (ASX), LEE'S PHARM (HKEx), ARCUS BIOSCIENCES INC (NYSE), STARPHARMA HOLDINGS LIMITED (ASX), KADMON HLDGS INC (NYSE), TELIX PHARMACEUTIC (ASX), DPHARMA (Bursa), 22ND CENTURY GROUP INC (NYSE American), STANDARD DIVERSIFIED INC (NYSE American), ENZO BIOCHEM INC (NYSE), PALATIN TECHNOLOGIES INC (NYSE American), BBI LIFE SCI (HKEx), PFENEX INC (NYSE American), CYNATA THERAPEUTICS LTD (ASX), BIOTIME INC (NYSE American), UNI-BIO GROUP (HKEx), NEUREN PHARMACEUTICALS LTD (ASX), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), HEMISPHERX BIOPHARMA INC (NYSE American), PORT (SET), RESAPP HEALTH LIMITED (ASX), IBIO INC (NYSE American), SYNTHETIC BIOLOGICS INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), CEL-SCI CORP (NYSE American), IMMUTEP LTD (ASX), CT ENTERPRISE (HKEx), REGENT PACIFIC (HKEx), IMUGENE LIMITED (ASX), PHYLOGICA LIMITED (ASX), ORTHOCELL LIMITED (ASX), ZELDA THERAPEUTICS LTD (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), BIOTRON (ASX), RHINOMED LIMITED (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), INVEX THERAPEUTICS LTD NPV (ASX), EXTRAWELL PHAR (HKEx), BIOSINO BIO-TEC (HKEx), MEMPHASYS LTD (ASX), ONCOSIL MEDICAL LIMITED (ASX), ORAGENICS INC (NYSE American), ADALTA LTD (ASX), ISORAY INC (NYSE American), PATRYS LIMITED (ASX), PROTEOMICS INTL LABORATORIES LTD (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), KAZIA THERAPEUTICS LIMITED (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), ALTERITY THERAPEUTICS LIMITED (ASX), IMMURON LIMITED (ASX), BIONOMICS LTD (ASX), REGENEUS LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), NANOVIRICIDES INC (NYSE American), ANTEO DIAGNOSTICS LIMITED (ASX), CELLMID LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), GENETIC TECHNOLOGIES (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), ANATARA LIFESCIENCES LTD (ASX), Suntar Eco-City^ (SGX), HOLISTA COLLTECH LIMITED (ASX), BIOXYNE LIMITED (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), BENITEC BIOPHARMA LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), QT Vascular (SGX), HAO WEN HLDGS (HKEx), ACTINOGEN MEDICAL LTD (ASX), MGRC (Bursa), MEGASUN (Bursa), CCP TECHNOLOGIES LTD (ASX), TBG DIAGNOSTICS LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), NOVITA HEALTHCARE LTD (ASX), MEDIBIO LIMITED (ASX), NANOLLOSE LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), BPH ENERGY LIMITED (ASX), GENERA BIOSYSTEMS LIMITED (ASX), ALCHEMIA LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.130
-6.37 %
10 Days --0.250
-11.57 %
20 Days --0.480
-20.08 %
Medium Term Return 3 Months --0.760
-28.46 %
6 Months --1.280
-40.13 %
1 Year --2.200
-53.53 %
Annualised Return Annualised --
-53.53 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.920 - 5.240 Change From 1 Year Low -0.010 % Change From 1 Year Low (%) -0.52
Change From 1 Year High -3.330 % Change From 1 Year High (%) -63.55
2 Years Range 1.920 - 5.240 Change From 2 Years Low -0.010 % Change From 2 Years Low (%) -0.52
Change From 2 Years High -3.330 % Change From 2 Years High (%) -63.55
5 Years Range 1.920 - 5.240 Change From 5 Years Low -0.010 % Change From 5 Years Low (%) -0.52
Change From 5 Years High -3.330 % Change From 5 Years High (%) -63.55
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Correvio Pharma Corp. operates as a pharmaceutical company, which engages in the provision of development and commercialization of medical products. It operates through the Europe and Rest of the World geographical segments. The firm focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. It offers the Brinavess and Aggrastat products to customers such as physicians, patients, and healthcare systems. The company was founded in 1986 and is headquartered in Vancouver, Canada.

Historical Price Data

Date Open High Low Close Volume VWAP
22 Jul 2019 1.950 1.950 1.855 1.910 17,946 -
19 Jul 2019 1.900 1.940 1.880 1.940 138,087 -
18 Jul 2019 1.950 1.950 1.840 1.880 44,589 -
17 Jul 2019 2.030 2.030 1.920 1.950 213,793 -
16 Jul 2019 2.040 2.060 1.940 2.040 145,723 -
15 Jul 2019 1.980 2.070 1.930 1.950 50,238 -
12 Jul 2019 2.026 2.026 1.940 2.000 38,992 -
11 Jul 2019 2.120 2.130 2.010 2.030 37,333 -
10 Jul 2019 2.254 2.254 2.100 2.170 57,245 -
09 Jul 2019 2.155 2.220 2.120 2.160 29,811 -
08 Jul 2019 2.330 2.330 2.080 2.220 54,667 -
05 Jul 2019 2.250 2.340 2.165 2.330 65,006 -
03 Jul 2019 1.976 2.240 1.976 2.240 110,675 -
02 Jul 2019 2.100 2.100 1.920 2.000 278,934 -
01 Jul 2019 2.130 2.190 2.070 2.070 55,317 -
28 Jun 2019 2.290 2.290 2.140 2.160 50,255 -
27 Jun 2019 2.270 2.330 2.240 2.250 816,750 -
26 Jun 2019 2.400 2.400 2.290 2.350 38,175 -
25 Jun 2019 2.340 2.390 2.320 2.390 165,534 -
24 Jun 2019 2.240 2.390 2.240 2.310 218,212 -
21 Jun 2019 2.380 2.400 2.250 2.290 47,153 -
20 Jun 2019 2.450 2.495 2.360 2.400 54,535 -
Summary
Current 2 Weeks
(09 Jul 2019 to 22 Jul 2019)
2.156 2.254 1.840 1.910 773,757 -
Previous 2 Weeks
(24 Jun 2019 to 08 Jul 2019)
2.240 2.390 1.840 2.220 1,853,525 -
4 Weeks from
(24 May 2019 to 21 Jun 2019)
2.430 2.460 1.840 2.290 2,083,426 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.